According to SurModics's latest financial reports and stock price the company's current number of shares outstanding is 14,102,000. At the end of 2023 the company had 14,102,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 14.1 M | 0.85% |
2022 | 13.98 M | 0.76% |
2021 | 13.87 M | 1.54% |
2020 | 13.66 M | 1.48% |
2019 | 13.46 M | 0.76% |
2018 | 13.36 M | 2.32% |
2017 | 13.06 M | -1.03% |
2016 | 13.2 M | 1.8% |
2015 | 12.96 M | -1.96% |
2014 | 13.22 M | -3.86% |
2013 | 13.75 M | -6.13% |
2012 | 14.65 M | -16.14% |
2011 | 17.47 M | 0.54% |
2010 | 17.38 M | -0.07% |
2009 | 17.39 M | -1.62% |
2008 | 17.68 M | -1.84% |
2007 | 18.01 M | -2.39% |
2006 | 18.45 M | 0.11% |
2005 | 18.43 M | 4.9% |
2004 | 17.57 M | 0.69% |
2003 | 17.45 M | 0.98% |
2002 | 17.28 M | 3.01% |
2001 | 16.78 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 2,407,200,000 | 16,969.92% | ๐บ๐ธ USA |
Abbott Laboratories ABT | 1,734,076,358 | 12,196.67% | ๐บ๐ธ USA |
Thermo Fisher Scientific TMO | 387,000,000 | 2,644.29% | ๐บ๐ธ USA |
Agilent Technologies A | 293,000,000 | 1,977.72% | ๐บ๐ธ USA |
PerkinElmer
PKI | 126,285,000 | 795.51% | ๐บ๐ธ USA |
Alkermes ALKS | 166,607,000 | 1,081.44% | ๐ฎ๐ช Ireland |
Nektar Therapeutics
NKTR | 190,406,000 | 1,250.21% | ๐บ๐ธ USA |
Heron Therapeutics HRTX | 144,990,000 | 928.15% | ๐บ๐ธ USA |
Enzo Biochem ENZ | 50,490,000 | 258.03% | ๐บ๐ธ USA |